By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mundipharma AG 

St. Alban-Rheinweg 74

Basel    CH-4006  Switzerland
Phone: 41-61-2051112 Fax: 41-61-2051109


SEARCH JOBS


Industry
Pharmaceutical






Company News
SkyePharma Inc. (SKYE) Release: Flutiform® Launched In France €3 Million Milestone Receivable From Mundipharma AG 2/10/2014 9:34:03 AM
Mundipharma AG Research Becomes The Latest Pharmaceutical Company To Choose BioClinica, Inc.'s Industry-Leading Clinical Trial Management System 1/28/2014 11:04:16 AM
Hong Kong Authority Approves Mundipharma AG's Flutiform® (fluticasone propionate/formoterol fumarate), a New Treatment for Asthma 11/8/2013 7:15:07 AM
SkyePharma Inc. (SKYE) Release: flutiform® Launch in Italy Triggers €2 Million Milestone From Marketing Partner Mundipharma AG 6/20/2013 8:49:52 AM
Allos Therapeutics, Inc. (ALTH) and Mundipharma AG Announce Strategic Collaboration for FOLOTYN; Allos to Receive $50 Million Upfront; Potentially up to $310.5 Million 5/11/2011 6:52:33 AM
Skyepharma PLC (SKYE) - Re Agreement 3/31/2009 12:46:13 PM
Skyepharma PLC (SKYE) Research Update 1/21/2009 10:18:47 AM
Sosei Group Corporation Announces Buyback of the Commercialization Rights to AD 923 from Mundipharma AG 12/29/2008 6:59:33 AM
Mundipharma AG New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain 9/26/2007 9:06:53 AM
Skyepharma PLC (SKYE): $80 Million European Development And Marketing Agreement For Novel Pain Control Agent DepoBupivacaine(TM)10/19/2005 5:13:08 PM
12
//-->